2. News & RNS
3. Finance News
4. UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Thu, 17th Oct 2019 16:13

Friday 18 October
InterContinental Hotels Group	Q3 Results
London Stock Exchange Group	Q3 Results
Avast	Q3 Results
Monday 21 October
Trifast	Trading Statement
Tuesday 22 October
Gear4music	Half Year Results
St James's Place	Trading Statement
Travis Perkins	Trading Statement
Anglo American	Q3 Production Report
Bunzl	Trading Statement
McBride	Trading Statement
Whitbread	Half Year Results
Reckitt Benckiser	Trading Statement
On the Beach Group	Trading Statement
Wednesday 23 October
Hochschild Mining	Q3 Production Report
Softcat	Full Year Results
HarbourVest Global Private Equity	Half Year Results
Antofagasta	Q3 Production Report
Fresnillo	Q3 Production Report
Metro Bank	Q3 Results
Quilter	Trading Statement
Centamin	Q3 Results
Thursday 24 October
AstraZeneca	Q3 Results
Royal Bank of Scotland Group	Q3 Results
RELX	Q3 Results
Shoe Zone	Trading Statement
Braemar Shiping Services	Half Year Results
Polymetal International	Q3 Production
Alumasc Group	Trading Statement
KAZ Minerals	Q3 Results
RDI REIT	Full Year Results
C&C Group	Half Year Results
AJ Bell	Trading Statement
Brooks Macdonald Group	Trading Statement
Copyright 2019 Alliance News Limited. All Rights Reserved.

Related Shares

Astrazeneca (AZN)

12,156.00 (-14.00 / -0.12%%)

12,124.00 - 12,128.00

Relx (REL)

3,284.00 (-16.00 / -0.48%%)

3,280.00 - 3,282.00

Brooks Macdonald (BRK)

1,920.00 (-55.00 / -2.78%%)

1,920.00 - 1,970.00

Alumasc Group (ALU)

182.50 (0.00 / 0.00%%)

180.00 - 185.00

Braemar Shipping (BMS)

280.00 (-5.00 / -1.79%%)

268.00 - 280.00

Shoe Zone (SHOE)

192.50 (0.00 / 0.00%%)

190.00 - 195.00

C&C Group (CCR)

168.00 (1.80 / 1.08%%)

166.20 - 167.00

AJ Bell (AJB)

337.00 (2.00 / 0.60%%)

333.00 - 334.50

Today 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

Today 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negoti...

29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while a...